BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

363 related articles for article (PubMed ID: 2548413)

  • 21. Plasma human chorionic gonadotropin disappearance in hydatidiform mole: a central registry report from the Netherlands.
    Franke HR; Risse EK; Kenemans P; Houx PC; Stolk JG; Vooijs GP
    Obstet Gynecol; 1983 Oct; 62(4):467-73. PubMed ID: 6888825
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Value of the radioimmunological assay of HCG and its subunits in the diagnosis and follow-up of gestational trophoblastic disease].
    Delpont PJ; Ruf H; Blanc B; Gamerre M; Adrai J; Conte M; Dupont S; Bellia-Rousseau J
    Rev Fr Gynecol Obstet; 1985 Oct; 80(10):737-52. PubMed ID: 2417299
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Identification of patients with persistent trophoblastic disease after complete hydatidiform mole by using a normal 24-hour urine hCG regression curve.
    van Cromvoirt SM; Thomas CM; Quinn MA; McNally OM; Bekkers RL
    Gynecol Oncol; 2014 Jun; 133(3):542-5. PubMed ID: 24631700
    [TBL] [Abstract][Full Text] [Related]  

  • 24. A rapid solid-phase radioimmunoassay specific for human chorionic gonadotropin in gestational trophoblastic disease.
    Goldstein DP; Pastorfide GB; Osathanondh R; Kosasa TS
    Obstet Gynecol; 1975 May; 45(5):527-30. PubMed ID: 164644
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Serum levels of macrophage colony-stimulating factor in trophoblastic disease.
    Kohorn EI; Kacinski BM; Stanley ER
    Gynecol Oncol; 2001 Mar; 80(3):383-6. PubMed ID: 11263936
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Assessment of RIA kit for measuring pregnancy-specific beta 1 glycoprotein (SP1) and its clinical significance as a tumor marker (author's transl)].
    Tsujino D; Chida R; Sasaki Y; Someya K; Shibata K
    Radioisotopes; 1981 Sep; 30(9):502-4. PubMed ID: 6276932
    [No Abstract]   [Full Text] [Related]  

  • 27. [HCG and SP1 in serum of patients with hydatidiform mole and chorionepithelioma--relative serum levels of both proteins in correlation to malignancy of the trophoblastic disease].
    Braun P; Leyendecker G
    Arch Gynecol; 1979 Jul; 228(1-4):663-4. PubMed ID: 485549
    [No Abstract]   [Full Text] [Related]  

  • 28. Schwangerschaftsprotein 1 (SP1) in serum and cerebrospinal fluid of patients with gestational trophoblastic disease.
    Ho PC; Ma HK
    Br J Obstet Gynaecol; 1983 Apr; 90(4):317-22. PubMed ID: 6188478
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Radioimmunoassay of HCG and HCG beta in blood during pregnancy and trophoblastomas].
    Mputu L; Thomas K; Renaer M; Vorstermans M; de Muylder X; Ferin J
    J Gynecol Obstet Biol Reprod (Paris); 1977 Sep; 6(6):777-91. PubMed ID: 199644
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Circulating concentrations of specific placental proteins (human chorionic gonadotropin, pregnancy-specific beta-1 glycoprotein, and placental protein 5) in untreated gestational trophoblastic tumors.
    Lee JN; Salem HT; Al-Ani AT; Chard T; Huang SC; Ouyang PC; Wei PY; Seppälä M
    Am J Obstet Gynecol; 1981 Mar; 139(6):702-4. PubMed ID: 6971058
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Radioimmunoassay of the serum free beta-subunit of human chorionic gonadotropin in trophoblastic disease.
    Fan C; Goto S; Furuhashi Y; Tomoda Y
    J Clin Endocrinol Metab; 1987 Feb; 64(2):313-8. PubMed ID: 2432080
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Detection of hCG production in trophoblastic diseases by HCG beta carboxyl-terminal peptide].
    Shimizu T; Matsuura S; Mochizuki M
    Nihon Sanka Fujinka Gakkai Zasshi; 1983 Oct; 35(10):1759-66. PubMed ID: 6195275
    [TBL] [Abstract][Full Text] [Related]  

  • 33. New criteria for the diagnosis of gestational trophoblastic disease.
    Romero R; Horgan JG; Kohorn EI; Kadar N; Taylor KJ; Hobbins JC
    Obstet Gynecol; 1985 Oct; 66(4):553-8. PubMed ID: 2995891
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Serum testosterone and dihydrotestosterone in patients with trophoblastic disease.
    Dawood MY; Saxena BB
    Obstet Gynecol; 1976 Jun; 47(6):684-8. PubMed ID: 180465
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Postevacuation hCG levels and risk of gestational trophoblastic neoplasia in women with complete molar pregnancy.
    Wolfberg AJ; Berkowitz RS; Goldstein DP; Feltmate C; Lieberman E
    Obstet Gynecol; 2005 Sep; 106(3):548-52. PubMed ID: 16135585
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Detecting and monitoring trophoblastic disease. New perspectives on measuring human chorionic gonadotropin levels.
    Cole LA; Kohorn EI; Kim GS
    J Reprod Med; 1994 Mar; 39(3):193-200. PubMed ID: 8035374
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Low risk of relapse after achieving undetectable HCG levels in women with complete molar pregnancy.
    Wolfberg AJ; Feltmate C; Goldstein DP; Berkowitz RS; Lieberman E
    Obstet Gynecol; 2004 Sep; 104(3):551-4. PubMed ID: 15339768
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Pregnancy-specific beta-1 glycoprotein (SP1) as a marker for tumors with or without trophoblastic character].
    Ruibal A; Comet R; Alvarez Moro FJ; Lafuerza A; Domenech-Torné FM; Salvador L
    Rev Esp Oncol; 1984; 31(3):427-34. PubMed ID: 6100801
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Radioimmunoassay of beta sub unit HCG following hydatidiform mole or chorionic carcinoma (author's transl)].
    Tscherne G; Pürstner P
    Geburtshilfe Frauenheilkd; 1979 Aug; 39(8):704-8. PubMed ID: 478273
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Serum progesterone monitoring in post-molar surveillance.
    Vasilev SA; Schlaerth JB; Ahn C; Sauer MV
    Gynecol Oncol; 1994 Sep; 54(3):288-91. PubMed ID: 7522199
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 19.